-
1.
公开(公告)号:US06514409B2
公开(公告)日:2003-02-04
申请号:US09756777
申请日:2001-01-10
申请人: Tomoki Kakiuchi , Koji Sekiguchi , Takeshi Suehiro , Shuhei Nakaji , Yoichi Matsumoto , Masato Takai , Nozomu Sugo , Hitoshi Tsuruta
发明人: Tomoki Kakiuchi , Koji Sekiguchi , Takeshi Suehiro , Shuhei Nakaji , Yoichi Matsumoto , Masato Takai , Nozomu Sugo , Hitoshi Tsuruta
IPC分类号: B01D6908
CPC分类号: B01D71/38 , B01D67/0011 , B01D67/0013 , B01D69/02 , B01D69/08 , B01D2323/12 , B01D2325/02 , B01D2325/04
摘要: A hollow fiber membrane made of an ethylene-vinyl alcohol polymer, comprises a dense layer existing in the inner surface and a porous layer existing in the layer other than the dense layer, wherein the hollow fiber membrane has a porosity of 60 to 90%, an overall mass transfer coefficient for myoglobin in a water-based system of not less than 0.003 cm/min., and a rejection rate for albumin in a bovine blood system of not less than 97%. The EVA hollow fiber membrane is useful for hemopurification membranes such as hemodialysis membranes, hemodiafiltration membranes, hemofiltration membranes and continuous hemofiltration membranes, and a process for producing the same.
摘要翻译: 由乙烯 - 乙烯醇聚合物制成的中空纤维膜包含存在于内表面的致密层和存在于除致密层以外的层中的多孔层,其中中空纤维膜的孔隙率为60〜90% 水性体系中的肌红蛋白的总传质系数不小于0.003cm /分钟,牛血液系统中白蛋白的排除率不低于97%。 EVA中空纤维膜可用于血液透析膜,血液透析膜,血液滤过膜和连续血液滤过膜等血液净化膜及其制造方法。
-
公开(公告)号:US07364660B2
公开(公告)日:2008-04-29
申请号:US10520864
申请日:2003-07-10
申请人: Masato Takai , Yoichi Matsumoto , Kouji Sekiguchi , Tomoki Kakiuchi , Hitoshi Tsuruta , Takao Shimizu
发明人: Masato Takai , Yoichi Matsumoto , Kouji Sekiguchi , Tomoki Kakiuchi , Hitoshi Tsuruta , Takao Shimizu
CPC分类号: B01D71/56 , B01D67/0009 , B01D69/08 , B01D2325/023 , B01D2325/22 , B01D2325/32
摘要: A polyamide having an equilibrium water absorption of not more than 10% is used as a main material. As a polyamide having an equilibrium water absorption of not.more than 10%, for example, a polyamide comprising a dicarboxylic acid component comprising 60-100 mol % of terephthalic acid and a diamine component comprising 60-100 mol % of 1,9-nonanediamine and/or 2-methyl-1,8-octanediamine is used. As a result, a porous membrane showing extremely small dimensional change even after a hot water treatment, and particularly useful as a medical separation membrane permitting an AC sterilization treatment and the like is obtained.
摘要翻译: 使用平衡吸水率不大于10%的聚酰胺作为主要材料。 作为平衡吸水率为10%以下的聚酰胺,例如可列举含有60-100摩尔%对苯二甲酸的二羧酸成分和含有60〜100摩尔%的1,9-壬二胺的二胺成分的聚酰胺 和/或2-甲基-1,8-辛二胺。 结果,即使在热水处理后也显示出极小的尺寸变化的多孔膜,并且特别可用作允许进行AC灭菌处理的医用分离膜等。
-
公开(公告)号:US20050145561A1
公开(公告)日:2005-07-07
申请号:US10520864
申请日:2003-07-10
申请人: Masato Takai , Yoichi Matsumoto , Kouji Sekiguchi , Tomoki Kakiuchi , Hitoshi Tsuruta , Takao Shimizu
发明人: Masato Takai , Yoichi Matsumoto , Kouji Sekiguchi , Tomoki Kakiuchi , Hitoshi Tsuruta , Takao Shimizu
CPC分类号: B01D71/56 , B01D67/0009 , B01D69/08 , B01D2325/023 , B01D2325/22 , B01D2325/32
摘要: A polyamide having an equilibrium water absorption of not more than 10% is used as a main material. As a polyamide having an equilibrium water absorption of not.more than 10%, for example, a polyamide comprising a dicarboxylic acid component comprising 60-100 mol % of terephthalic acid and a diamine component comprising 60-100 mol % of 1,9-nonanediamine and/or 2-methyl-1,8-octanediamine is used. As a result, a porous membrane showing extremely small dimensional change even after a hot water treatment, and particularly useful as a medical separation membrane permitting an AC sterilization treatment and the like is obtained.
摘要翻译: 使用平衡吸水率不大于10%的聚酰胺作为主要材料。 作为平衡吸水率为10%以下的聚酰胺,例如可列举含有60-100摩尔%对苯二甲酸的二羧酸成分和含有60〜100摩尔%的1,9-壬二胺的二胺成分的聚酰胺 和/或2-甲基-1,8-辛二胺。 结果,即使在热水处理后也显示出极小的尺寸变化的多孔膜,并且特别可用作允许进行AC灭菌处理的医用分离膜等。
-
-